These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2141037

  • 21. Most CD8+ cells in skin lesions of CD3+ CD4+ mycosis fungoides are CD3+ T cells that lack CD11b, CD16, CD56, CD57, and human Hanukah factor mRNA.
    Wood GS, Dubiel C, Mueller C, Abel EA, Hoppe RT, Edinger A, Weissman I, Warnke RA.
    Am J Pathol; 1991 Jun; 138(6):1545-52. PubMed ID: 1828937
    [Abstract] [Full Text] [Related]

  • 22. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ, Falkenburg JH, Fibbe WE, Veenhof WF, Hamilton M, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1989 Mar 01; 142(5):1774-80. PubMed ID: 2521886
    [Abstract] [Full Text] [Related]

  • 23. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS, Thiele DL, Lipsky PE.
    J Immunol; 1987 Dec 01; 139(11):3886-95. PubMed ID: 3500232
    [Abstract] [Full Text] [Related]

  • 24. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A, Shiku H, Nakayama E.
    J Immunol; 1993 Jun 01; 150(11):4900-10. PubMed ID: 8496592
    [Abstract] [Full Text] [Related]

  • 25. CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report.
    Warzynski MJ, Barbour SD, Winkler-Pickett RT, Ortaldo JR.
    Cytometry; 1994 Dec 15; 18(4):231-6. PubMed ID: 7534677
    [Abstract] [Full Text] [Related]

  • 26. Long-term culture growth of CD4-CD8- lymphocytes exhibiting elevated non-MHC-restricted cytotoxic activity.
    Montesoro E, Bulgarini D, Carè A, Masciulli R, Giannella G, Mariani G, Samoggia P, Salvo G, Habetswallner D, Testa U.
    J Biol Regul Homeost Agents; 1991 Dec 15; 5(1):10-8. PubMed ID: 1715635
    [Abstract] [Full Text] [Related]

  • 27. Evidence for involvement of the gamma, delta T cell antigen receptor in cytotoxicity mediated by human alloantigen-specific T cell clones.
    Rivas A, Koide J, Cleary ML, Engleman EG.
    J Immunol; 1989 Mar 15; 142(6):1840-6. PubMed ID: 2466078
    [Abstract] [Full Text] [Related]

  • 28. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G, Malorni W, Donelli G.
    Ann Ist Super Sanita; 1990 Mar 15; 26(3-4):369-84. PubMed ID: 2151107
    [Abstract] [Full Text] [Related]

  • 29. A combined immunodeficiency with oligoclonal CD8+, V beta 3-expressing, cytotoxic T lymphocytes in the peripheral blood.
    Kuijpers KC, van Dongen JJ, van der Burg P, Roos MT, Vonk J, de Abreu R, de Korte D, van Noesel CJ, Weening RS, van Lier RA.
    J Immunol; 1992 Nov 15; 149(10):3403-10. PubMed ID: 1431114
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2002 Jul 15; 8(7):2052-60. PubMed ID: 12114403
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.
    Anderson P, Nagler-Anderson C, O'Brien C, Levine H, Watkins S, Slayter HS, Blue ML, Schlossman SF.
    J Immunol; 1990 Jan 15; 144(2):574-82. PubMed ID: 2104899
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC, Herbelin A, Machavoine F, Vicari A, Gombert JM, Papiernik M, Dy M.
    J Immunol; 1995 Nov 15; 155(10):4544-50. PubMed ID: 7594451
    [Abstract] [Full Text] [Related]

  • 39. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 40. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones.
    Strack P, Martin C, Saito S, Dekruyff RH, Ju ST.
    Eur J Immunol; 1990 Jan 01; 20(1):179-84. PubMed ID: 1968392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.